LASANSELasa Supergenerics LimitedMinimalNeutral
Announced Fri, 29 May · 21:13 IST

Lasa Supergenerics Limited has informed the Exchange about related Party Transactions

LASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.3%1-day move
₹8.45
prior close
₹8.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-1.9-2.2-9.3-9.3-9.1-5.9-9.5-9.1-11.1-10.1
Up moveDown movePending
AI summary

Lasa Supergenerics Limited has filed its quarterly and annual related party transaction disclosure for the period ending March 31, 2026. The filing covers 16 related party transactions totaling Rs 618 lakhs in approved value. Key transactions include director remuneration to Mr. Omkar Herlekar (Rs 100 lakhs), Mr. Umesh Pawar (Rs 100 lakhs), and Company Secretary Mrs Mitti Jain (Rs 100 lakhs). Independent Directors received sitting fees of Rs 8 lakhs each. Notably, the company gave a donation of Rs 200 lakhs to Dr. Omkar Herlekar Foundation, a common director entity. CFO remuneration was split between Mr. Ravi Shankar Kabra (Rs 30 lakhs) and Ms. Varsha Joshi (Rs 8 lakhs).

Likely market impact

The transaction values appear routine for director compensation and governance purposes. The Rs 200 lakh donation to a foundation linked to the Chairman warrants attention as it represents a material related party outflow that may attract regulatory scrutiny.